In the past week, XRAY stock has gone down by -4.24%, with a monthly decline of -9.84% and a quarterly plunge of -26.38%. The volatility ratio for the week is 4.90%, and the volatility levels for the last 30 days are 3.35% for DENTSPLY Sirona Inc The simple moving average for the last 20 days is -4.05% for XRAY stock, with a simple moving average of -27.42% for the last 200 days.
Is It Worth Investing in DENTSPLY Sirona Inc (NASDAQ: XRAY) Right Now?
XRAY has 36-month beta value of 0.97. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 4 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for XRAY is 197.56M, and currently, short sellers hold a 4.98% ratio of that float. The average trading volume of XRAY on January 15, 2025 was 3.38M shares.
XRAY) stock’s latest price update
DENTSPLY Sirona Inc (NASDAQ: XRAY) has seen a decline in its stock price by -3.22 in relation to its previous close of 18.66. However, the company has experienced a -4.24% decline in its stock price over the last five trading sessions. accesswire.com reported 2025-01-14 that NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=122949&wire=1 or contact Joseph E. Levi, Esq.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Evercore ISI repeating the rating for XRAY by listing it as a “In-line.” The predicted price for XRAY in the upcoming period, according to Evercore ISI is $20 based on the research report published on January 07, 2025 of the current year 2025.
Mizuho, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $21. The rating they have provided for XRAY stocks is “Neutral” according to the report published on December 04th, 2024.
XRAY Trading at -6.45% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.70% of loss for the given period.
Volatility was left at 3.35%, however, over the last 30 days, the volatility rate increased by 4.90%, as shares sank -9.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.85% lower at present.
During the last 5 trading sessions, XRAY fell by -4.24%, which changed the moving average for the period of 200-days by -45.78% in comparison to the 20-day moving average, which settled at $18.82. In addition, DENTSPLY Sirona Inc saw -4.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 5,000 shares at the price of $18.37 back on Nov 18 ’24. After this action, LUCIER GREGORY T now owns 71,730 shares of DENTSPLY Sirona Inc, valued at $91,850 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 1,000 shares at $18.28 during a trade that took place back on Nov 15 ’24, which means that LUCIER GREGORY T is holding 16,000 shares at $18,279 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.11. The total capital return value is set at -0.05. Equity return is now at value -14.08, with -5.97 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.93. The interest coverage ratio of the stock is -3.61.
Currently, EBITDA for the company is 232.0 million with net debt to EBITDA at 25.95. When we switch over and look at the enterprise to sales, we see a ratio of 1.44. The receivables turnover for the company is 5.81for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
To put it simply, DENTSPLY Sirona Inc (XRAY) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
